Home/Filings/4/0001493152-24-047998
4//SEC Filing

Aminov Erez 4

Accession 0001493152-24-047998

CIK 0001904286other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 4:15 PM ET

Size

6.7 KB

Accession

0001493152-24-047998

Insider Transaction Report

Form 4
Period: 2024-11-19
Aminov Erez
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2024-11-19$1.39/sh55,410$77,0201,105,790 total
  • Sale

    Common Stock

    2024-11-20$1.27/sh44,590$56,6291,061,200 total
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions.

Documents

1 file

Issuer

MIRA PHARMACEUTICALS, INC.

CIK 0001904286

Entity typeother

Related Parties

1
  • filerCIK 0001986112

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:15 PM ET
Size
6.7 KB